HI SB940 | 2022 | Regular Session
Note: Carry Over of previous SB940
Status
Spectrum: Partisan Bill (Democrat 7-0)
Status: Introduced on January 27 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 27 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires providers authorized to prescribe opioids to discuss with patients certain risks associated with controlled substances that are opioids prior to issuing initial opioid prescriptions for the treatment of acute pain. Requires providers to include a note acknowledging the discussion of the risks associated with opioids in the patient's medical record.
Title
Relating To Opioids.
Sponsors
| Sen. Mike Gabbard [D] | Sen. Laura Acasio [D] | Sen. Stanley Chang [D] | Sen. Bennette Misalucha [D] |
| Sen. Sharon Moriwaki [D] | Sen. Michelle Kidani [D] | Sen. Maile Shimabukuro [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-12-10 | Carried over to 2022 Regular Session. | |
| 2021-01-29 | Senate | Referred to HTH, CPN/JDC. |
| 2021-01-27 | Senate | Passed First Reading. |
| 2021-01-27 | Senate | Introduced. |
Same As/Similar To
SB940 (Carry Over) 2021-01-29 - Referred to HTH, CPN/JDC.
Subjects
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=940&year=2022 |
| Text | https://www.capitol.hawaii.gov/session2022/bills/SB940_.HTM |
